Kalispell hospital has anti-malarial drug for potential use for severe COVID-19 cases

The Kalispell Regional Medical Center cited patient confidentiality when it recently declined to comment about whether its efforts to save the life of a critically ill COVID-19 patient in late March included the use of the anti-malarial drug hydroxychloroquine.